Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 358

Which market comes out first in a recovery?

The quickest, sharpest decline in history (-35% in 23 days on the S&P500 index) was followed by the quickest, sharpest rebound (up 30% in four weeks), so the question now is: Where do we go from here?

We have seen some encouraging news of peaks in the pandemic across many Asian and European countries as well as some US states. Many governments are reopening their economies gradually. However, this process will be gradual and staggered, not a straight line.

The recovery will be slow and it is unlikely to be seamless. Moreover, fundamentals are still deteriorating rapidly, and we do not know how bad the economic picture will become. 

Bear markets take time

Since their March 23 trough, most equity markets have retraced at least 50% of their losses. Is this a bear market rally or a V-shaped recovery? We believe that another leg down is likely.

Looking back, history suggests a V-shaped market recovery is rare. Since the 1920s, the S&P500 index has experienced 14 bear markets (as defined by a 20% decline). During these periods, there were 19 bear market rallies in excess of 15% before falling again.

Only one bear market (1932-33) saw markets recover to prior peaks within a year. Historically, it has taken 15 months (on median) for the MSCI All Country World Index to recover to prior peaks after bottoming, and about 20 months for the S&P500, the MSCI Europe and the TOPIX indexes to recover to prior peaks. It took four years after the GFC for global markets to return to pre-crisis levels.

The S&P500 index retracement to about 50% of its losses acted as a ceiling during the dot com crisis and the GFC. Policymakers have been more pro-active and aggressive this time than in the past, which should help shore up confidence and limit the damage.

In our view, markets are being optimistic. The recent rebound is not pricing in the reality of the situation, the risks that still lie ahead, nor the scars left behind. Yes, markets typically front-run economic data, and fiscal and monetary support is massive, but markets cannot ignore fundamentals, both in terms of growth and earnings.

In addition, the ramp up in activity is likely to be much slower than anticipated, suggesting it will take quarters and not months to recuperate output losses. As such and given the ‘quality’ of the rebound so far, we believe that markets will likely see another leg down in the coming months.

What comes out first?

The scale and scope of central bank support makes a strong case for credit markets as a first investment allocation – “buy what the central banks are buying” is a pretty easy adage to follow. Moreover, while spreads did not reach the heights of 2008 levels, they are much more attractive than they have been for some time, offering attractive entry points. We prefer investment grade over high yield, given much more central bank support and less default risk.

Expectations that US growth will hold up and recover better than Europe means earnings should recover quicker, which also supports the US. Emerging Asia should benefit from being first-in-first-out of the crisis and should outperform other Emerging Markets regions.

We are likely to see some long-term legacy from this crisis as well. The de-globalisation trend that began even before the pandemic will be exacerbated as reliance on global supply chains has created vulnerabilities. As such, we expect the repatriation of strategic industries such as healthcare and defence to begin in earnest. Given even bigger reliance on technology, protecting this industry will become paramount.

We believe that downside risks remain and that equity markets are likely to remain volatile and see another down leg. Nonetheless, active managers have the opportunity to take advantage of market dislocations in this environment. In the current context, humility and risk management are key words.

 

Esty Dwek is Head of Global Market Strategy at Natixis Investment Managers Solutions. This article contains general information only as it does not take into account any individual’s personal financial circumstances.

 

RELATED ARTICLES

What will stop the market returning to its highs?

Depression or recovery? The risk of time

Will value stocks benefit from the market's inflection point?

banner

Most viewed in recent weeks

11 lessons from my lousy $50K profit on Afterpay

Afterpay listed at $1 in 2016 and traded recently at $70. How should an investor treat a small holding in a 70-bagger when each new level defies the experts? Should true believers let the profits run?

How much bigger can the virus bubble get?

Stocks have rallied hard creating a virus bubble, but will this run for years or collapse in a matter of months? The market is giving a second chance to leave so head for the exit before there's a rush.

Which companies will do well in the turmoil of 2020?

While the shutting of Australia’s borders to international travellers and quarantine measures is damaging to certain sectors of the economy, it is not uniformly negative for all companies.

Share trading is the new addiction

The ability to buy and sell cheaply and quickly in small parcels is both the biggest drawback and benefit of shares. But it encourages people who should not go near the market to use it as a casino.

What is happening with SMSFs? Part 1

Taking a realistic view of the median ‘operating expense’ of an SMSF shows they cost less to run than previously claimed. Look at this granular breakdown and see how the costs of running your SMSF compare.

Why are we convinced 'this time it's different'?

Investors tend to overstate the impact on investments when something significant happens and they assume the future will be different. COVID-19 has been dramatic, but is it really that unusual?

Latest Updates

Investment strategies

11 lessons from my lousy $50K profit on Afterpay

Afterpay listed at $1 in 2016 and traded recently at $70. How should an investor treat a small holding in a 70-bagger when each new level defies the experts? Should true believers let the profits run?

Shares

How did shares perform in FY20 and where to from here?

Compared with most years in the last decade, FY20 performed poorly due to the virus, and now dividends are falling. There are three things to watch this year as support policies are wound back.

Shares

Which companies will do well in the turmoil of 2020?

While the shutting of Australia’s borders to international travellers and quarantine measures is damaging to certain sectors of the economy, it is not uniformly negative for all companies.

Investment strategies

Six types of big data are unlocking real insights

Data science is increasingly embedded into the research process of investment teams with the resources to exploit new technologies. The way the data is integrated and interpreted is crucial.

Investing

Will value stocks benefit from the market's inflection point?

As the world gradually emerges from the aftermath of COVID-19, many are questioning if now is value’s time to shine? How can value stocks deliver outperformance in today’s environment?

Fixed interest

Less than 1% for 100 years: watch the price risk on long bonds

Do you think investors can only lose heavily on bonds if the credit defaults? When bondholders accept 0.88% for 100 years, there is great potential for serious pain somewhere along the journey.

Economy

Five industries profoundly changed by COVID-19

Even when the virus is finally contained, the business landscape will look very different. A critical issue is the ability of consumers to find product substitutes. Many people like what they find.

Exchange traded products

Wirecard shows not all ethical ETFs pass the smell test

The strictness of screening processes can vary between ethical ETFs, and many rely on indices without additional oversight. This can result in stock inclusions that may not pass the ethical ‘smell test’.

Sponsors

Alliances

© 2020 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.